Table 1.

Baseline patient and clinical characteristics of MHE versus MAU following randomisation (n = 196)

	Total sample n = 196
	MAU = 98	MHE n = 98
Gender, n (%)
Male	74 (75.5)	74 (75.5)
Mean age at trial start (SD)	14.3 (2.7)	14.3 (2.8)
Ethnicity, n (%)
White	39 (39.8)	46 (46.9)
Black	35 (35.7)	23 (23.5)
Asian	2 (2.0)	1 (1.0)
Mixed	13 (13.3)	15 (15.3)
Other or not stated	9 (9.2)	13 (13.3)
Level of deprivation, n (%)
1st (least deprived)	22 (23.2)	25 (25.8)
2nd	21 (22.1)	27 (27.8)
3rd	24 (25.2)	24 (24.7)
4th (most deprived)	28 (29.5)	21 (21.7)
Co‐morbid diagnosis, n (%)
ADHD	48 (49.0)	39 (39.8)
LD	14 (14.3)	11 (11.2)
Emotional disorder	14 (14.3)	17 (17.4)
Mean CGAS score (SD)	53.1 (10.7)	54.6 (8.8)
Mean days of active care (SD)	592.1 (196.4)	563.0 (210.4)
Mean attended F2F events (SD)	6.0 (10.2)	9.1 (21.0)
Mean baseline SDQ Scores (SD)
Emotional	5.3 (2.5)	5.5 (2.8)
Conduct	4.3 (2.3)	4.5 (2.4)
Hyperactivity	7.5 (2.3)	7.7 (2.1)
Peer difficulties	4.8 (2.3)	5.2 (2.3)
Prosocial	5.2 (2.6)	5.4 (2.3)
Impact score	5.9 (3.4)	5.6 (2.9)
Total difficulties	22.1 (5.5)	23.0 (5.3)

SD, standard deviation.